Neurotrophin receptor-based strategies for alzheimer's disease

Current Alzheimer Research

Volumn 2, Issue 2, 2005, Pages 167-169

  Longo, Frank M ^a   Massa, Stephen M ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; NERVE PROTEIN; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; PROTEIN P75; SORTILIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN INJURY; CHOLINERGIC SYSTEM; CONFERENCE PAPER; HUMAN; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING;

ALZHEIMER DISEASE; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; NERVE GROWTH FACTORS; RECEPTORS, NERVE GROWTH FACTOR;

EID: 20844452391     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567205053585819     Document Type: Conference Paper

References (43)

1. Rabizadeh S, Bredesen DE. Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). Cytokine Growth Factor Rev 14: 225-39 (2003).
2. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4: 299-309 (2003).
3. Teng KK, Hempstead BL. Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol Life Sci 61: 35-48 (2004).
4. Pattarawarapan M, Burgess K. Molecular basis of neurotrophin-receptor interactions. J Med Chem 46: 5277-91 (2003).
5. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427: 843-8 (2004).
6. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 29: 211-30 (2003).
7. Apfel SC. Is the therapeutic application of neurotrophic factors dead? Ann Neurol 51: 8-11 (2002).
8. Tuszynski MH. Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol 1: 51-7 (2002).
9. Tuszynski MH, Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Prog Brain Res 146: 441-9 (2004).
10. Pardridge WM. Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins. Adv Exp Med Biol 513: 397-430 (2002).
11. Bergmann I, Reiter R, Toyka KV, Koltzenburg M. Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75. Neurosci Lett 255: 87-90 (1998).
12. Day-Lollini PA, Stewart GR, Taylor MJ, Johnson RM, Chellman GJ. Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor. Exp Neurol 145: 24-37 (1997).
13. Pizzo DP, Winkler J, Sidiqi I, Waite JJ, Thal LJ. Modulation of sensory inputs and ectopic presence of Schwann cells depend upon the route and duration of nerve growth factor administration. Exp Neurol 178: 91-103 (2002).
14. Behrens MM, Strasser U, Lobner D, Dugan LL. Neurotrophin-mediated potentiation of neuronal injury. Microsc Res Tech 45: 276-84 (1999).
15. Koh JY, Gwag BJ, Lobner D, Choi DW. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 268: 573-5 (1995).
16. McDonald JW, Stefovska VG, Liu XZ, Shin H, Liu S, Choi DW. Neurotrophin potentiation of iron-induced spinal cord injury. Neuroscience 115: 931-9 (2002).
17. Kim HJ, Hwang JJ, Behrens MM, Snider BJ, Choi DW, Koh JY. TrkB mediates BDNF-induced potentiation of neuronal necrosis in cortical culture. Neurobiol Dis 14: 110-9 (2003).
18. Lobner D, Golner S, Hjelmhaug J. Neurotrophic factor effects on oxidative stress-induced neuronal death. Neurochem Res 28: 749-56 (2003).
19. Dechant G, Barde YA. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 5: 1131-6 (2002).
20. Barde YA. Death of injured neurons caused by the precursor of nerve growth factor. Proc Natl Acad Sci U S A 101: 5703-4 (2004).
21. Mufson EJ, Kordower JH. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc Natl Acad Sci U S A 89: 569-73 (1992).
22. Hu XY, Zhang HY, Qin S, Xu H, Swaab DF, Zhou JN. Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol 178: 104-11 (2002).
23. Zhang Y, Hong Y, Bounhar Y, Blacker M, Roucou X, Tounekti O, et al. p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity. J Neurosci 23: 7385-94 (2003).
24. Harrington AW, Leiner B, Blechschmitt C, Arevalo JC, Lee R, Morl K, et al. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc Natl Acad Sci USA 101: 6226-30 (2004).
25. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, Longo FM, et al. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36: 375-86 (2002).
26. Xie Y, Longo FM. Neurotrophin small-molecule mimetics. Prog Brain Res 128: 333-47 (2000).
27. Saragovi HU, Zaccaro MC. Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites. Curr Pharm Des 8: 2201-16(2002).
28. Longo FM, Xie Y, Massa SM. Neurotrophin small molecule mimetics: candidate therapeutic agents for neurological disorders. Curr Med Chem in press: (2005).
29. Longo FM, Vu TK, Mobley WC. The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. Cell Regul 1: 189-95 (1990).
30. Longo FM, Manthorpe M, Xie YM, Varon S. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J Neurosci Res 48: 1-17 (1997).
31. Massa SM, Xie Y, Longo FM. Alzheimer's therapeutics: neurotrophin domain small molecule mimetics. J Mol Neurosci 20: 323-6 (2003).
32. Kawasumi M, Hashimoto Y, Chiba T, Kanekura K, Yamagishi Y, Ishizaka M, et al. Molecular mechanisms for neuronal cell death by Alzheimer's amyloid precursor protein-relevant insults. Neurosignals 11: 236-50 (2002).
33. Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, et al. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 443: 136-53 (2002).
34. Yaar M, Zhai S, Fine RE, Eisenhauer PB, Arble BL, Stewart KB, et al. Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 277: 7720-5 (2002).
35. Yankner BA, Caceres A, Duffy LK. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A 87: 9020-3 (1990).
36. Rabizadeh S, Bitler CM, Butcher LL, Bredesen DE. Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A 91: 10703-6 (1994).
37. Troy CM, Rabacchi SA, Xu Z, Maroney AC, Connors TJ, Shelanski ML, et al. beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem 77: 157-64 (2001).
38. Bozyczko-Coyne D, Saporito MS, Hudkins RL. Targeting the JNK pathway for therapeutic benefit in CNS disease. Curr Drug Targets CNS Neurol Disord 1: 31-49 (2002).
39. Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67: 203-33 (2002).
40. Park HS, Kim MS, Huh SH, Park J, Chung J, Kang SS, et al. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J Biol Chem 277: 2573-8 (2002).
41. Wei W, Wang X, Kusiak JW. Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem 277: 17649-56 (2002).
42. Peng S, Wuu J, Mufson EJ, Fahnestock M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63: 641-9 (2004).
43. Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18: 210-20 (2001).